Impact of fibrinogen levels on angiographic progression and 12-year survival in the armed forces regression study.
Repository Usage Stats
We assessed the role of fibrinogen levels on angiographic progression and long-term survival among 111 patients with coronary disease enrolled in the Armed Forces Regression Study (AFREGS). Baseline fibrinogen levels and quantitative coronary angiography were performed initially and at 30 months. Progression or nonregression of coronary disease was more prevalent in patients with high fibrinogen than patients with normal fibrinogen (66.1% vs 45.5%; P = .022). Twelve-year cardiovascular (CV) mortality was substantially higher if fibrinogen was elevated (17.9% vs 3.6%, P = .016). Among patients with elevated fibrinogen and angiographic progression or nonregression, there were 10 deaths and all were CV. Elevated levels of fibrinogen predict the angiographic progression of existing coronary disease and likelihood of CV death. Among patients with elevated levels of fibrinogen, angiographic progression identifies a significantly increased likelihood of a fatal CV event.
Coronary Artery Disease
Predictive Value of Tests
Published Version (Please cite this version)10.1177/0003319709360525
Publication InfoDevendra, Ganesh P; Hart, Stephen A; Krasuski, Richard Andrew; & Whitney, EJ (2010). Impact of fibrinogen levels on angiographic progression and 12-year survival in the armed forces regression study. Angiology, 61(4). pp. 333-337. 10.1177/0003319709360525. Retrieved from http://hdl.handle.net/10161/11041.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record